Alzheon sets IPO pricing terms
Framingham, Massachusetts-based Alzheon Inc, a biopharmaceutical company focused on brain health, memory and aging, has priced 5 million shares of its IPO at between $13 and $15 per share. The stock will trade on the NASDAQ under the ticker symbol "ALZH." Citigroup Global Markets Inc. and Piper Jaffray & Co. are the lead underwriters. Alzheon's backers include Ally Bridge Group.
2 April 2018•2 mins read
